EVOFEM BIOSCIENCES INC's ticker is EVFM and the CUSIP is 30048L104. A total of 2 filers reported holding EVOFEM BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | -96.3% | 2,145 | -97.0% | 0.00% | – |
| Q4 2021 | $27,000 | -20.6% | 72,260 | +55.6% | 0.00% | – |
| Q3 2021 | $34,000 | +277.8% | 46,432 | +441.4% | 0.00% | – |
| Q2 2021 | $9,000 | -79.1% | 8,577 | -64.4% | 0.00% | – |
| Q1 2021 | $43,000 | -51.7% | 24,120 | -34.8% | 0.00% | – |
| Q4 2020 | $89,000 | +74.5% | 37,009 | +70.8% | 0.00% | – |
| Q3 2020 | $51,000 | -36.2% | 21,667 | -22.6% | 0.00% | – |
| Q2 2020 | $80,000 | +73.9% | 27,992 | +225.5% | 0.00% | – |
| Q1 2020 | $46,000 | -58.2% | 8,599 | -51.8% | 0.00% | – |
| Q4 2019 | $110,000 | +93.0% | 17,834 | +59.8% | 0.00% | – |
| Q3 2019 | $57,000 | +200.0% | 11,163 | +286.9% | 0.00% | – |
| Q2 2019 | $19,000 | +1800.0% | 2,885 | +766.4% | 0.00% | – |
| Q1 2019 | $1,000 | -95.5% | 333 | -93.8% | 0.00% | – |
| Q4 2018 | $22,000 | +2100.0% | 5,376 | +1514.4% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 333 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | -50.0% | 333 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | – | 333 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mirador Capital Partners LP | 2,807,681 | $955,000 | 0.19% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 1,100,000 | $374,000 | 0.13% |
| JB CAPITAL PARTNERS LP | 23,184 | $118,000 | 0.03% |
| Westside Investment Management, Inc. | 10,000 | $2,974,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 47,103 | $3,067,000 | 0.01% |
| Platform Technology Partners | 13,000 | $4,000 | 0.00% |
| Bayesian Capital Management, LP | 35,900 | $12,000 | 0.00% |
| RBF Capital, LLC | 69,551 | $25,000 | 0.00% |
| HAP Trading, LLC | 20,100 | $22,000 | 0.00% |
| Advisor Resource Council | 10,000 | $3,000 | 0.00% |